Advanced search
Publication Cover
Orthopedic Research and Reviews Volume 14, 2022 - Issue
Submit an article Journal homepage
167
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

A Patient with Bone Fragility, Multiple Fractures, Osteosarcoma, and the Variant c.143A>G in the IFITM5 Gene: A Case Report

Harry Pachajoa1 Genetics Division, Fundación Valle del Lili, Cali, Colombia;2 Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Icesi, Cali, ColombiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2672-0439
ORCID Icon &
Sebastian Giraldo-Ocampo3 Departamento de Microbiología, Universidad del Valle, Cali, Colombia
Pages 453-458 | Received 24 Aug 2022, Accepted 18 Oct 2022, Published online: 28 Nov 2022

References

  • Forlino A, Cabral WA, Barnes AM, Marini JC. New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol. 2011;7:540–557. doi:10.1038/nrendo.2011.81
  • Van Dijk FS, Cobben JM, Kariminejad A, et al. Osteogenesis imperfecta: a review with clinical examples. Mol Syndromol. 2011;2:1–20. doi:10.1159/000332228
  • Semler O, Garbes L, Keupp K, et al. A mutation in the 5′-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type v with hyperplastic callus. Am J Hum Genet. 2012;91:349–357. doi:10.1016/j.ajhg.2012.06.011
  • Cho TJ, Lee KE, Lee SK, et al. A single recurrent mutation in the 5′-UTR of IFITM5 causes osteogenesis imperfecta type v. Am J Hum Genet. 2012;91:343–348. doi:10.1016/j.ajhg.2012.06.005
  • Glorieux FH, Rauch F, Plotkin H, et al. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res. 2000;15:1650–1658. doi:10.1359/jbmr.2000.15.9.1650
  • Reich A, Bae AS, Barnes AM, et al. Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression. J Clin Endocrinol Metab. 2015;100:E325–E332. doi:10.1210/jc.2014-3082
  • Mäkitie RE, Pekkinen M, Morisada N, et al. A novel IFITM5 variant associated with phenotype of osteoporosis with calvarial doughnut lesions: a case report. Calcif Tissue Int. 2021;109:626–632. doi:10.1007/s00223-021-00878-5
  • Cao YJ, Wei Z, Zhang H, Zhang ZL. Expanding the clinical spectrum of osteogenesis imperfecta type V: 13 additional patients and review. Front Endocrinol. 2019;10:1–9. doi:10.3389/fendo.2019.00375
  • Zhytnik L, Maasalu K, Duy BH, et al. IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients. Hum Genomics. 2019;13:25.
  • Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424. doi:10.1038/gim.2015.30
  • Mortier GR, Cohn DH, Cormier-Daire V, et al. Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet Part A. 2019;179:2393–2419. doi:10.1002/ajmg.a.61366
  • Glorieux FH, Moffatt P. Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation. J Bone Miner Res. 2013;28:1519–1522. doi:10.1002/jbmr.1982
  • Vonderlind HC, Jessel M, Knobel A, Juergensen I, Struewer J. Late onset hyperplastic callus formation in osteogenesis imperfecta type V simulating osteosarcoma—A case report. Int J Surg Case Rep. 2020;69:83–86. doi:10.1016/j.ijscr.2020.03.024
  • Deng Y, Huo Y, Li J. Case report: hyperplastic callus of the femur mimicking osteosarcoma in osteogenesis imperfecta type V. Front Endocrinol. 2021;12:1–6. doi:10.3389/fendo.2021.622674
  • Moffatt P, Gaumond MH, Salois P, et al. Bril: a novel bone-specific modulator of mineralization. J Bone Miner Res. 2008;23:1497–1508. doi:10.1359/jbmr.080412
  • Hanagata N. IFITM5 mutations and osteogenesis imperfecta. J Bone Miner Metab. 2016;34:123–131. doi:10.1007/s00774-015-0667-1
  • Takahashi S, Okada K, Nagasawa H, Shimada Y, Sakamoto H, Itoi E. Osteosarcoma occurring in osteogenesis imperfecta. Virchows Arch. 2004;444:454–458. doi:10.1007/s00428-004-0985-5
  • Wang X, Song Z, Hu B, Chen Z, Chen F, Cao C. MicroRNA-642a-5p inhibits colon cancer cell migration and invasion by targeting collagen type I α1. Oncol Rep. 2021;45:933–944. doi:10.3892/or.2020.7905
  • Guo Y, Lu G, Mao H, et al. Mir-133b suppresses invasion and migration of gastric cancer cells via the col1a1/tgf-β axis. Onco Targets Ther. 2020;13:7985–7995. doi:10.2147/OTT.S249667
  • Li M, Wang J, Wang C, et al. Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived COL1A1 and facilitates ovarian cancer metastasis. Exp Cell Res. 2020;394:112153. doi:10.1016/j.yexcr.2020.112153
  • Zhang J, Walsh MF, Wu G, et al. Germline mutations in predisposition genes in pediatric cancer. N Engl J Med. 2015;373:2336–2346. doi:10.1056/NEJMoa1508054
  • Thorby-Lister A, Högler W, Hodgson K, et al. Cumulative radiation exposure from medical imaging and associated lifetime cancer risk in children with osteogenesis imperfecta. Bone. 2018;114:252–256. doi:10.1016/j.bone.2018.06.021

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.